Ongoing

AUSCEP (Australian Clinical Entrepreneur Program)

Funding

Varies

Region

VIC

Overview

AUSCEP is designed to empower clinicians with an entrepreneurial spirit to bridge the gap between healthcare and innovation. The program offers a blend of immersive in-person pitstops, webinars, and access to a network of seasoned mentors to help clinicians transform groundbreaking ideas into impactful solutions across Medtech, Digital Health, Biotechnology, and Service Delivery.

Eligibility Requirements

Open to clinicians with an entrepreneurial spirit, including those at idea stage, 'intrapreneurs' within organisations, or those looking to start their own business. Works with clinicians across Medtech, Digital Health, Biotechnology, and Service Delivery sectors.

Who Can Apply

Startups

Relevant Industries

HealthMedtechDigital HealthBiotechnology

How to Apply

Applications are submitted through the official government portal. Review the eligibility criteria carefully before applying, and ensure all supporting documents are prepared.

Visit the official application page

Disclaimer: Grant information is sourced from official government websites and updated regularly. Always verify current eligibility and deadlines on the official program page before applying.

Related Grants

Ongoing·VIC

ACTIVATE

A six-month accelerator program for Victorian digital and digitally enabled medical technology companies poised for significant growth. The program combines critical elements of Masterclass and ANDHealth+ programs, providing world-class content, hands-on coaching, deep domain expertise, and supported implementation to help companies develop robust business and investment cases.

Ongoing·Commonwealth

Cooperative Research Centres (CRC) Grants - Cell Therapy Manufacturing

The Cell Therapy Manufacturing Cooperative Research Centre (CTM CRC) is funded by the Australian Government to develop innovative cell therapy manufacturing technologies. The CRC focuses on creating stem cell delivery systems for chronic wound treatment and developing scalable production methods for immune cell therapies used in cancer and other medical conditions.

Ongoing·Commonwealth·$850,000

CRC Projects Round 17 - Novel precision medicine for FacioScapuloHumoral Muscular Dystrophy (FSHD)

This project aims to apply advances in RNA and peptide chemistry to develop a new generation of precision medicines with potential to modify disease in FacioScapuloHumoral Dystrophy (FSHD). The innovation addresses barriers to systemic delivery, muscle and cell uptake, stability and safety. The project will generate proof of concept for muscle targeting of precision therapeutics in relevant models of FSHD.